https://doi.org/10.4081/monaldi.2013.26
Roflumilast: the fourth Mousquetaire in COPD pharmacological treatment
Submitted: August 18, 2015
Accepted: August 18, 2015
Published: August 19, 2015
Accepted: August 18, 2015
Abstract Views: 896
PDF: 585
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Balbi, Bruno. 2015. “Roflumilast: The Fourth Mousquetaire in COPD Pharmacological Treatment”. Monaldi Archives for Chest Disease 79 (3-4). https://doi.org/10.4081/monaldi.2013.26.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Pasqualina Calisi, Raffaele Griffo, Postoperative atrial fibrillation: etiopathogenesis, prevention and therapy , Monaldi Archives for Chest Disease: Vol. 62 No. 2 (2004): Cardiac series
- Costantina Prota, Rodolfo Citro, Angelo Silverio, Roberto Ascoli, Corrado Naddeo, Giovanni Vitale, Federico Piscione, Thrombus straddling a patent foramen ovale , Monaldi Archives for Chest Disease: Vol. 80 No. 3 (2013): Cardiac series
- G. Passalacqua, E. Compalati, M. Schiappoli, G. Senna, Complementary and alternative medicine for the treatment and diagnosis of asthma and allergic diseases , Monaldi Archives for Chest Disease: Vol. 63 No. 1 (2005): Pulmonary series
- Maurizio Giuseppe Abrignani, Furio Colivicchi, Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk , Monaldi Archives for Chest Disease: Vol. 80 No. 2 (2013): Cardiac series
- Cengiz Özdemir, Sinem Nedime Sökücü, Ayşegül Akbaş, Sezin Altay, Ahmet Levent Karasulu, Levent Dalar, Endobronchial Watanabe Spigot in the treatment of bronchobiliary fistula , Monaldi Archives for Chest Disease: Vol. 81 No. 1-2 (2015): Pulmonary series
- F. Frati, C. Incorvaia, F. Marcucci, L. Sensi, G. Di Cara, P. Puccinelli, S. Dal Bo, Dose dependence of efficacy but not of safety in sublingual immunotherapy , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- Giuseppe Patti, Ludmilla Mantione, Edoardo Bressi, Antonio Bisignani, Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Stefania Angela Di Fusco, Nadia Aspromonte, Stefano Aquilani, Luca Mele, Furio Colivicchi, Emergency reversal of vitamin-K antagonists related over-anticoagulation: case report and brief overview on the role of Prothrombin Complex Concentrate , Monaldi Archives for Chest Disease: Vol. 80 No. 4 (2013): Cardiac Series
- Dimitrios Papadopoulos, Panagiotis Misthos, Maria Chorti, Vlasios Skopas, Alexandra Nakou, Napoleon Karagianidis, Achilleas Lioulias, Vasiliki Filaditaki, Unilateral pulmonary hypoplasia in an adult patient , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
- Yusuf Kayar, Nüket Bayram Kayar, Tuncay Şahutoğlu, Venkatanarayana Gangarapu, Spontaneous pneumomediastinum following pneumonia in a 23-year-old male patient , Monaldi Archives for Chest Disease: Vol. 83 No. 1-2 (2016): Pulmonary series
<< < 34 35 36 37 38 39 40 41 42 43 > >>
You may also start an advanced similarity search for this article.
